Deepak Sahu, MBA, explains how HEOR studies are important for generating useful effectiveness data for success of medical technologies.

Adoption, utilization, and payment of medical technologies require safety, efficacy, and effectiveness data to convince the purchaser (provider, payer, or patient). In the United States (US) healthcare system, long-term data on effectiveness is critical to maintain payer confidence in the technology and serve the population. Therefore, a well-designed Health Economics and Outcomes Research (HEOR) study is vital for generating short- and long-term effectiveness data. In addition, this webinar discusses a stepwise strategic approach to developing HEOR data for medical technology.

Key Topics Include:

  • Learn strategic approach to HEOR in medical devices
  • Understand the current framework in the US
  • Understand how HEOR is being used to convince various stakeholders including investors
  • Understand concepts through a case study
  • Analyze relevance of HEOR approach for reimbursement


Deepak Sahu, MBA, MPH


Alira Health


Related Content

Endpoints at #DIA23

Endpoints at #DIA23

The political issues circling the FDA this year could potentially ripple into biopharma on a scale that’s never been seen before. All eyes are on the FDA’s response to recent court rulings around the abortion pill mifepristone — and the potential effects on other approvals that might be questioned. What does the future look like, exactly? Join Endpoints’ Senior Editor Zachary Brennan in an expert panel to unpack what may come next. We’ll also touch on how the FDA is looking for new ways to spur more rare disease drug development with a fireside chat.